Quintiles has been named as the ‘Best CRO in Asia’ at the 2014 BioPharma Asia Industry Awards. This is the third time in the event’s four-year history that Quintiles has received the honour. The award recognises the contract research organisation that has best demonstrated an ongoing commitment to improve clinical research in Asia and help customers succeed.
“This award reflects Quintiles’ ability to improve our customers’ probability of success by combining market knowledge with superior service,” said Ken Lee, Vice President and Regional General Manager for Southeast Asia, Quintiles, who accepted the award. “For 20 years we have been helping our customers navigate Asia’s complex and changing healthcare environment. It’s wonderful to be acknowledged for our excellence in bringing knowledge and people together for a healthier world.”
Anand Tharmaratnam, Senior Vice President and Head of Asia-Pacific, Quintiles said, “I’d like to dedicate to this to our employees, whose excellence made it possible; to our valued customers; and to patients worldwide whose lives and quality of life depend on new and better medicines.”
EP News Bureau – Mumbai